NOWATCH
- Industry
- Health Technology
- Founded Year
- 2020
- Headquarters
- Keizersgracht 316, 1016 EZ Amsterdam, Netherlands
- Employee Count
- 0
Key People
- Hylke Muntinga - Co-founder & CEO
- Timothe Manschot - Co-founder & COO
- David de Picciotto - Co-founder & CCO
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The founding team comprises first-time entrepreneurs with over a decade of experience in their respective fields.
While the founders bring significant experience, their lack of previous success in MedTech entrepreneurship may pose challenges in navigating the industry's complexities.
- Clinical Need
-
Aspect: Good
Summary: The product addresses a significant need for stress monitoring and management.
With rising awareness of mental health, the demand for stress monitoring devices is growing. However, the market's competitiveness necessitates differentiation.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering similar stress-tracking devices.
Companies like Apple, Fitbit, and Garmin have introduced stress-tracking features, making it challenging for new entrants to capture significant market share.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing accurate stress monitoring technology presents moderate technical challenges.
Accurate stress detection requires sophisticated algorithms and sensor technology, posing moderate technical challenges in development and validation.
- Patent
-
Aspect: Applied
Summary: The company has applied for patents but lacks granted ones.
While applied patents indicate innovation, the absence of granted patents means the company currently lacks enforceable intellectual property protection.
- Financing
-
Aspect: Self/None
Summary: The company appears to be self-funded with no disclosed external financing.
Without external funding, the company may face challenges in scaling operations and marketing efforts to compete effectively in the market.
- Regulatory
-
Aspect: Concept Stage
Summary: The product is at the concept stage with no regulatory approvals.
Navigating regulatory pathways is essential for market entry, and being at the concept stage indicates these processes are still forthcoming.
Opportunity Rollup
- Odds of Success
- 3.7
- Peak Market Share
- 5.7
- Segment CAGR
- 9.3%
- Market Segment
- Stress Tracking Devices
- Market Sub Segment
- Wearable Stress Monitoring Devices
Year Post Launch | Market Penetration (%) |
---|---|
1 | 0.29 |
2 | 0.86 |
3 | 2.00 |
4 | 3.99 |
5 | 5.70 |
Key Takeaway
NOWATCH operates in a growing market with increasing demand for stress monitoring devices but faces challenges from competition and technical development.